RMSL.US REMSleep Holdings Inc
- Market cap
- USD 1.91M
- P/E
- -
- P/B
- 235.09x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is RMSL.US undervalued?
Graham numberThe Graham number of REMSleep Holdings Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
REMSleep Holdings Inc fundamental analysis
No fundamental analysis for REMSleep Holdings Inc yet.
REMSleep Holdings Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About REMSleep Holdings Inc
REMSleep Holdings, Inc., focuses on the development and distribution of products to help people affected by sleep apnea worldwide. The company offers DeltaWave CPAP interface device to treat patients with sleep apnea. It serves durable medical equipment providers, hospital and acute care facilities, sleep labs, physicians, sleep and neurology, and medical associations. The company is headquartered in Blackshear, Georgia.
Full company profileREMSleep Holdings Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
REMSleep Holdings Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 120K | 321K | 204K | 117K | 16.7K | 38.4K |
| Gross Profit | -917.00 | -4.36K | -12.6K | -17.5K | -49.2K | -57.6K | 72.3K | -757K | 18.0K | -31.4K | 0.00 |
| Operating Income | -197K | -651K | -294K | -2.34M | -470K | -426K | -1.22M | -1.77M | -794K | -2.77M | -535K |
| EBITDA | -196K | -647K | -353K | -3.45M | -515K | -368K | -1.19M | -1.67M | -861K | -2.60M | -506K |
| Net Income | -197K | -654K | -413K | -4.29M | -1.79M | -4.74M | -1.49M | -1.78M | -1.08M | -3.02T | -787K |
| EPS | -0.03 | -0.10 | -0.05 | -0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1,926 | 0.00 |
| Balance Sheet | |||||||||||
| Total Assets | 12.8K | 184K | 57.1K | 253K | 231K | 3.50M | 3.36M | 1.21M | 592K | 340K | 154K |
| Total Liabilities | 312K | 681K | 637K | 1.26M | 1.10M | 880K | 652K | 276K | 255K | 308K | 435K |
| Shareholders' Equity | -299K | -498K | -580K | -1.01M | -870K | 2.62M | 2.71M | 931K | 337K | 32.1K | -281K |
| Cash & Short-term Investments | 108.00 | 2.01K | 16.6K | 120K | 114K | 3.38M | 1.84M | 719K | 463K | 215B | 0.00 |
| Total Debt | 85.3K | 50.0K | 282K | 313K | 277K | 417K | 451K | 178K | 25.6K | 78.4K | 157K |
| Cash Flow | |||||||||||
| Operating Cash Flow | -133K | -94.9K | -112K | -236K | -335K | -350K | -2.23M | -791K | -683K | -503B | -837K |
| Capital Expenditure | 10.3K | 42.5K | 42.5K | 86.9K | 36.7K | 67.3K | 122K | 148K | 125K | 0.00 | 16.00 |
| Free Cash Flow | -133K | -94.9K | -154K | -323K | -372K | -417K | -2.36M | -939K | -808K | -503B | -761K |
| Ratios | |||||||||||
| ROE | - | - | - | - | - | -181.2% | -54.9% | -191.0% | -320.2% | -9,420,185,889.8% | - |
| ROA | -1,534.4% | -355.8% | -723.1% | -1,691.8% | -774.7% | -135.6% | -44.2% | -147.4% | -182.2% | -888,961,490.0% | -511.4% |
| Net Profit Margin | - | - | - | - | - | -3,964.4% | -463.6% | -872.7% | -919.9% | -18,062,914,897.4% | -2,051.0% |
| Debt to Equity | - | - | - | - | - | 0.16x | 0.17x | 0.19x | 0.08x | 2.45x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
REMSleep Holdings Inc dividends
REMSleep Holdings Inc has not paid dividends in the last 9 fiscal years.
Last stock split: 1:20 on Jun 30, 2017.
Who owns REMSleep Holdings Inc
- Insiders 2.08%
- Institutions 0.01%
- Public & others 97.91%
- Shares outstanding 1.74B
- Free float 1.73B
REMSleep Holdings Inc company profile
- Company name
- REMSleep Holdings Inc
- Ticker
- RMSL.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 2
- Fiscal year end
- December
- Address
- 3222 HWY 84, Blackshear, GA, United States, 31516
- Phone
- 902 590 2001
- Website
- remsleep.com
About REMSleep Holdings Inc
REMSleep Holdings, Inc., focuses on the development and distribution of products to help people affected by sleep apnea worldwide. The company offers DeltaWave CPAP interface device to treat patients with sleep apnea. It serves durable medical equipment providers, hospital and acute care facilities, sleep labs, physicians, sleep and neurology, and medical associations. The company is headquartered in Blackshear, Georgia.
REMSleep Holdings Inc management
4- Ms. Teresita RubioTreasurer & Chairman
- Dr. Sanja Pekovic Ph.D.Chief Executive Officer · born 1955
- Peter DowneyInterim President
- Ms. Irina VeselinovicSecretary · born 1982